CTOR vs TM · $105.2M cap vs P/E 9.7, rev $234.60B
Citius Oncology, Inc. (CTOR) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
CTOR does not have a complete income-statement cache yet.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
CTOR currently screens at market cap $105.2M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the CTOR and TM stock pages for the full models.
Not investment advice.